Brief: Syndax Pharmaceuticals Files For Mixed Shelf- SEC Filing
27/02/2024 23:36
Feb 27 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O :
* SYNDAX PHARMACEUTICALS INC FILES FOR MIXED SHELF- SEC
FILING
* SYNDAX PHARMACEUTICALS-SALES AGREEMENT PROSPECTUS COVERS
OFFERING OF UP TO $156.8 MILLION OF COMMON STOCK THAT MAY BE
ISSUED AND SOLD FROM TIME TO TIME
Source text for Eikon: ID:n0001193125-24-048135
Further company coverage: SNDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syndax Pharmaceuticals
See all newsBrief: Syndax Announces Topline Results From Maxpire Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Syndax Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Syndax Q2 revenue jumps 92% on Revuforj, Niktimvo demand
Brief: Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million